» Articles » PMID: 21490916

Alternative Perspectives: How Chinese Medicine Understands Hypercholesterolemia

Overview
Journal Cholesterol
Date 2011 Apr 15
PMID 21490916
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of cardiovascular disease, albeit under the auspices of other clinical descriptors to those described in western biomedicine, has a long history in China. Chinese Medicine (CM) is guided by unique philosophical underpinnings and theories. There are differences in how the heart is conceptualised traditionally in CM compared to biomedicine. This paper focusses on how hypercholesterolemia is understood from within the Chinese medical paradigm, including its aetiology, pathogenesis, and treatment. A brief overview of the key characteristics and theories of CM is given to provide context. Modern science has demonstrated that many Chinese herbs have cholesterol-lowering properties. Examples of research into individual herbs and medicinal formulae, combinations of herbs are presented. At a more sophisticated level, some researchers are challenging some of the very assumptions upon which CM is based, including applicability of CM theory to modern clinical entities such as hypercholesterolemia, and are seeking intersections of knowledge between CM and biomedicine that may extend CM theory.

Citing Articles

An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Chi M, Chao J, Ko C, Huang S Front Pharmacol. 2022; 13:900693.

PMID: 36188612 PMC: 9520573. DOI: 10.3389/fphar.2022.900693.


Acupuncture and Neural Mechanism in the Management of Low Back Pain-An Update.

Lim T, Ma Y, Berger F, Litscher G Medicines (Basel). 2018; 5(3).

PMID: 29941854 PMC: 6164863. DOI: 10.3390/medicines5030063.


Rhein Elicits In Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway.

Bounda G, Zhou W, Wang D, Yu F Evid Based Complement Alternat Med. 2015; 2015:329831.

PMID: 26221172 PMC: 4484835. DOI: 10.1155/2015/329831.

References
1.
Luo Q, Cai Y, Yan J, Sun M, Corke H . Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004; 76(2):137-49. DOI: 10.1016/j.lfs.2004.04.056. View

2.
Ko K, Mak D, Chiu P, Poon M . Pharmacological basis of 'Yang-invigoration' in Chinese medicine. Trends Pharmacol Sci. 2004; 25(1):3-6. DOI: 10.1016/j.tips.2003.11.002. View

3.
OBrien K, Abbas E, Zhang J, Guo Z, Luo R, Bensoussan A . An investigation into the reliability of Chinese medicine diagnosis according to Eight Guiding Principles and Zang-Fu Theory in Australians with hypercholesterolemia. J Altern Complement Med. 2009; 15(3):259-66. DOI: 10.1089/acm.2008.0204. View

4.
Gao C, Xu Y . [Effect of allitridi on cAMP level of arterial wall and plasma of hypercholesterolemic rabbits]. Zhong Xi Yi Jie He Za Zhi. 1991; 11(4):227-8, 198. View

5.
Berthold H, Sudhop T . Garlic preparations for prevention of atherosclerosis. Curr Opin Lipidol. 1998; 9(6):565-9. DOI: 10.1097/00041433-199812000-00008. View